atropine has been researched along with 7-methylxanthine in 2 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (7-methylxanthine) | Trials (7-methylxanthine) | Recent Studies (post-2010) (7-methylxanthine) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 27 | 0 | 15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohno-Matsui, K; Vutipongsatorn, K; Yokoi, T | 1 |
| Tkatchenko, AV; Tkatchenko, TV | 1 |
2 review(s) available for atropine and 7-methylxanthine
| Article | Year |
|---|---|
Current and emerging pharmaceutical interventions for myopia.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atropine; Clinical Trials as Topic; Disease Progression; Drug Evaluation, Preclinical; Drug Therapy; Humans; Ketorolac Tromethamine; Mydriatics; Myopia; Pharmaceutical Preparations; Riboflavin; Vitamin B Complex; Xanthines | 2019 |
Pharmacogenomic Approach to Antimyopia Drug Development: Pathways Lead the Way.
Topics: Animals; Atropine; Drug Development; Eye; Humans; Myopia; Pharmacogenetics; Refraction, Ocular; Signal Transduction; Xanthines | 2019 |